304 related articles for article (PubMed ID: 34591597)
21. Differential diagnosis of parotid gland tumors using apparent diffusion coefficient, texture features, and their combination.
Muraoka H; Kaneda T; Kondo T; Okada S; Tokunaga S
Dentomaxillofac Radiol; 2023 Apr; 52(4):20220404. PubMed ID: 37015250
[TBL] [Abstract][Full Text] [Related]
22. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients.
Gudmundsson JK; Ajan A; Abtahi J
J Appl Oral Sci; 2016; 24(6):561-567. PubMed ID: 28076460
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of MR imaging findings differentiating parotid basal cell adenomas from other parotid tumors.
Murayama Y; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Yasumatsu R; Yamamoto H; Yabuuchi H; Ishigami K
Eur J Radiol; 2021 Nov; 144():109980. PubMed ID: 34601323
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram.
Qi J; Gao A; Ma X; Song Y; Zhao G; Bai J; Gao E; Zhao K; Wen B; Zhang Y; Cheng J
Front Oncol; 2022; 12():937050. PubMed ID: 35898886
[TBL] [Abstract][Full Text] [Related]
25. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of CT-based radiomics nomogram for the classification of benign parotid gland tumors.
Zheng M; Chen Q; Ge Y; Yang L; Tian Y; Liu C; Wang P; Deng K
Med Phys; 2023 Feb; 50(2):947-957. PubMed ID: 36273307
[TBL] [Abstract][Full Text] [Related]
27. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
[TBL] [Abstract][Full Text] [Related]
28. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
30. US in preoperative evaluation of parotid gland neoplasms.
Gerwel A; Kosik K; Jurkiewicz D
Otolaryngol Pol; 2015; 69(2):27-33. PubMed ID: 26224227
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
[TBL] [Abstract][Full Text] [Related]
32. Investigation of Sonographic Criteria for Reliable Identification of T1-T2 Low-Grade Malignant Tumors of the Parotid Gland.
Berner F; Koch M; Müller SK; Schapher M; Grundtner P; Iro H; Mantsopoulos K
Ultrasound Med Biol; 2021 Mar; 47(3):471-477. PubMed ID: 33309444
[TBL] [Abstract][Full Text] [Related]
33. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
34. [Imaging in parotid tumors: US versus MRT].
Steiner E; Turetschek K; Wunderbaldinger P; Staniszewski K; Franz P; Steurer M; Millesi W
Rofo; 1994 May; 160(5):397-405. PubMed ID: 8173049
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma ex pleomorphic adenoma of the parotid gland.
Kashiwagi N; Murakami T; Chikugo T; Tomita Y; Kawano K; Nakanishi K; Mori K; Tomiyama N
Acta Radiol; 2012 Apr; 53(3):303-6. PubMed ID: 22287150
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance and inter-operator variability of apparent diffusion coefficient analysis for differentiating pleomorphic adenoma and carcinoma ex pleomorphic adenoma: comparing one-point measurement and whole-tumor measurement including radiomics approach.
Wada T; Yokota H; Horikoshi T; Starkey J; Hattori S; Hashiba J; Uno T
Jpn J Radiol; 2020 Mar; 38(3):207-214. PubMed ID: 31820265
[TBL] [Abstract][Full Text] [Related]
37. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
[TBL] [Abstract][Full Text] [Related]
38. The role of fine needle aspiration biopsy in deep lobe parotid tumors: Comparison of preoperative cytology and postoperative histopathologic results.
Seyhun N; Doğan U; Çalış ZAB; Kaya MF; Hasçiçek SÖ; Turgut S
Am J Otolaryngol; 2021; 42(1):102590. PubMed ID: 33045535
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
Rong X; Zhu Q; Ji H; Li J; Huang H
Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
[TBL] [Abstract][Full Text] [Related]
40. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
